Amphetaminil

Drugbox
IUPAC_name = 2-phenyl-2-(1-phenylpropanyl-2-amino)acetonitrile

---

width= 200
CAS_number= 17590-01-1
ATC_prefix=
ATC_suffix=
PubChem= 28615
DrugBank=
C=17 | H=18 | N=2
molecular_weight = 250.338
bioavailability=
metabolism =
elimination_half-life=
excretion =
pregnancy_category =
legal_status =
routes_of_administration=

Amphetaminil (Aponeuron) is a stimulant drug derived from amphetamine, which was developed in the 1970s and used for the treatment of obesity, [Harris LS. The stimulants and hallucinogens under consideration: a brief overview of their chemistry and pharmacology. "Drug and Alcohol Dependence" 1986; 17:107.] ADHD, [Meyer-Probst B, Vehreschild T. Influencing the lack of concentration in hyperkinetic schoolchildren with Aponeuron. "Psychiatrie, Neurologie und Medizinische Psychologie (Leipz)" 1976; 28:491.] [Paclt I, Florian J, Brunclikova J, Ruzickova I. Effect of Aponeuron in the treatment of children with hyperkinetic syndrome. (Czech). "Ceska a Slovenska Psychiatrie". 1996 May;92 Suppl 1:41-57.] and narcolepsy. [Schlesser JL. Drugs Available Abroad - A Guide to Therapeutic Drugs Approved Outside the US. MEDEX Books, Detroit, 1991.] It has largely been withdrawn from clinical use following problems with abuse. [Winter E. Drug abuse and dependence of the amphetamine type with special regard to Amphetaminil (Aponeuron(R)). (German). "Psychiatrie, Neurologie und Medizinische Psychologie (Leipz)". 1976 Sep;28(9):513-25.]

References